Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
Chapter 5 Market Segmentation by Type
5.1 Neurology Devices
5.1.1 By Type of Device
5.1.1.1 Cerebrospinal Fluid Management Devices
5.1.1.1.1 Cerebral External Drainage
5.1.1.1.2 Cerebral Shunts
5.1.1.2 Interventional Neurology Devices
5.1.1.2.1 Neurothrombectomy Devices
5.1.1.2.1.1 Snare Devices
5.1.1.2.1.2 Suction Aspiration Devices
5.1.1.2.1.3 Clot Retrievers
5.1.1.2.2 Cerebral Balloon Devices
5.1.1.2.2.1 Filter Devices
5.1.1.2.2.2 Balloon Occlusion Devices
5.1.1.2.2.3 Carotid Artery
5.1.1.2.3 Aneurysm Coiling & Embolization
5.1.1.2.3.1 Liquid Embolic Agents Embolic Coils
5.1.1.2.3.2 Flow Diversion Devices Liquid Embolic Agents
5.1.1.2.3.3 Embolic Coils
5.1.1.2.4 Support Devices
5.1.1.3 Neurosurgery Devices
5.1.1.3.1 Ultrasonic Aspirators Neuroendoscopes
5.1.1.3.2 Neuroendoscopes Stereotactic Systems
5.1.1.3.3 Stereotactic Systems Aneurysm Clips
5.1.1.3.4 Aneurysm Clips
5.1.1.4 Neurostimulation Devices
5.1.1.4.1 Deep Brain Stimulation Devices
5.1.1.4.2 Sacral Nerve Stimulation Devices
5.1.1.4.3 Spinal Cord Stimulation Devices
5.1.1.4.4 Vagus Nerve Stimulation Devices
5.1.1.4.5 Gastric Electric Stimulation Devices
Chapter 6 Market Segmentation by geography
6.1 Introduction
6.2 Mexico
Chapter 7 Competitive Landscape
7.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
7.2 Strategies Adopted by Top Companies
7.3 Market Share Analysis
Chapter 8 Company Profiles
8.1Johnson and Johnson
8.1.1. Company Overview
8.1.2. Business Segments
8.1.3. Financial Performance (Public Enterprises)
8.1.4. SWOT Analysis
8.2Magstim
8.3 St Jude Medical
8.4 Stryker
8.5 W.L. Gore and Associates
8.6 Cyberonics
8.7KMT Hepatech
8.8 Novartis
8.9 Mallinckrodt
8.10 BSN Medical
8.11 Octapharma
8.12 Bayer
8.13 Eli Lilly
8.14 Medplast
8.15 Pfizer
Chapter 9 Market Insights
9.1 Insights of Industry Experts
9.2 Investment Opportunities
9.3 Analyst Opinion
Chapter 10 Appendix
10.1 List of Tables
10.2 List of Figures
